-
03-28 2017
Clinical trial of ACC007, an innovative anti-HIV drug has been officially approved by China Food and Drug Administration (CFDA)
-
11-03 2016
Innovative Antitumor Drug ACC006 Received CFDA Approval for Clinical Trials
-
09-12 2016
Innovative Anti-HIV Drug ACC007 Officially Submit Investigational New Drug Application
-
03-30 2016
On March 16, 2016, the formulation workshop of Ganquan manufacturing site has received the Drug Production License.
-
12-24 2015
Aidea has signed a cooperation agreement with Kainos Medicine, Inc. for two antitumor innovative drug development projects.
News Center
